Govt Job: For M.Pharm, M.Sc under SERB-CRG funded project

Established in 1955 by the visionary industrialist Mr. BM Birla, BIT Mesra was founded with a clear vision to offer its young minds a space, where their imagination could take wings and their ideas fruition.

For over 6 decades now, the institute has nurtured minds with a rich heritage of academic excellence, developing learning frameworks that have been well ahead of times.

Post : Junior Research Fellow (JRF)

Applications are invited for the post of Junior Research Fellow in following project funded under SERB-CRG (2022-2025)

Project title : Development of Novel Antileukemics Through the Structural and Functional Studies of Engineered and Chimeric Plant-Type Asparaginases File No.: CRG//2021/006543

Name of PI& Co-PI : Dr. K K Pradhan, Dr. V K Nigam & Dr. H R Singh

Eligibility : M.Tech./ M.S/ M.Pharm./ M.Sc. in Bioengineering / Biotechnology / Pharm. Biotechnology. NET / GATE / GPAT or other national level examination qualifiers will be preferred.

Desirable skills : Design of Protein expression & purification, Local engineering (circular permutation, linker modification, motifs exchange, randomization),QbD, chimera-genesis and Exposure in SDS-PAGE as well as XRD techniques.

Duration : Initially for a period of 01 year & may be extended for a additional 02 year upon satisfactory performance

Felloship Rs/-pm : 31,000/- + HRA as applicable (First 2 Years) 35,000/- + HRA as applicable (Third Year)

Date and time of Interview :26th April 2022 & at 9.15 AM

Venue : Department of Pharmaceutical Sciences& Technology, BIT-Mesra

• Interested candidates are required to bring all original Certificates and testimonials along with one set of duly attested photocopy on the interview date. No TA/DA will be provided for attending the Interview.

• Candidates may please forward their Bio-data in advance to Dr. Kishanta Kumar Pradhan (Principal Investigator of the Project) through e-mail (kkpradhan@bitmesra.ac.in)

• Candidates appearing for online/offline interview should covey in advance to the PI.

• Selected candidate are expected to enroll for Ph.D. program of the institute after fulfilling admission criteria and would be given preference.

Terms & Conditions :
1. No TA/DA will be paid for attending the interview.
2. The above position is purely contractual.
3. Canvassing in any form will disqualify the candidate.

Related Posts

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

New Delhi: Serious legal gaps in the Drugs and Cosmetics Act, 1940, combined with acute shortages of manpower and infrastructure, continue to impede the Central Drugs Standard Control Organisation (CDSCO)…

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna: In a significant ruling that could have far-reaching implications for NDPS drug-related prosecutions involving common pharmaceutical compounds, the Patna High Court has held that Phenothiazine and Promethazine do not…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines